Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I

NCT01004406 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

59

Enrollment

FED

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DEVICE: intensive LDL-lowering therapy
DRUG: standard statin monotherapy

Sponsor

VA Office of Research and Development